Regional expansion Attentive Science is expanding in the Gulf region with Biosphere Labs in Abu Dhabi and a collaboration network across GCC, presenting a runway for sales of preclinical services, shared lab infrastructure access, and regionalized client support.

Strategic partnerships Recent partnerships with Masdar City, M42, Innovive, and regional distributors indicate a growth strategy built on co-marketing and integrated life-science solutions, offering cross-sell opportunities for pharmacokinetics, toxicology, and vivarium products/services.

Clinical-readiness focus As a GLP/non-GLP preclinical leader with FDA inspection and AAALAC accreditation, the company appeals to biotech and pharma sponsors seeking compliant, high-quality data and expanded pharmacology capabilities for drug discovery programs.

Leadership and expertise A senior team with deep experience in pharmacokinetics, safety pharmacology, and toxicology, plus newly added professionals, supports credibility in complex studies and can be leveraged to upsell advanced study designs and consultative services.

Growth-ready revenue Revenue range of $10M–$25M and a lean headcount (11–50) suggest agile operations with opportunity to scale through regional labs, expanded test systems, and additional contract research offerings to capture increasing preclinical demand in biotech and pharma.